Mr. Roger Davenport serves as Partner at NovaQuest Capital Management. He serves as Chairman at Catalyst Clinical Research. He also serves as a Board Member at Clinical Ink. Mr. Davenport served as Vice Chairman, Board of Trustees at East Carolina University. In this role, he was instrumental in the carve-out of the company from Intuit and returning its core portal solution to a market leadership position. Operationally, he created a culture where the company was awarded "Best Places to Work" by the Triangle Business Journal. In less than 12 months, the company developed and released two new products inpatient payments and consumer patient record integration leveraging both cloud and mobile technologies. Prior to Medfusion, Mr. Davenport was Chairman and CEO of Medquist, the leader in transcription services before and after the privatization of the company. As Chairman and CEO, Mr. Davenport facilitated a transformation of the business through the acquisition of a speech technology company, rebranding the company M*Modal and leading the take-private process that resulted in the sale of the business to One Equity Partners. Mr. Davenport's previous experience also includes his time as President, Allscripts; CEO, Misys Healthcare; GM & EVP, Kodak Health Group (now Carestream Health) and executive leadership roles at Siemens, Shared Medical Systems. Mr. Davenport started his career at IBM where he spent 11 years in sales, sales leadership and executive management positions. He also serves as a Board Member at Silvergate Pharmaceuticals and InformedDNA. Mr. Davenport received an MBA from East Carolina University as well as a BSBA in Business. He serves as Board Member at CoreRx.